secwatch.observer — SEC 8-K summary
======================================

Issuer:     SS Innovations International, Inc. (SSII)
CIK:        0001676163
Form:       8-K
Filed at:   2026-05-13T12:30:18+00:00
Accession:  0001213900-26-055468
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SS Innovations Q1 revenue $11.1M (+117% YoY); net loss narrows to $3.6M; installations up 73%
--------------------------------------------------------------------------------

- Revenue $11.1M, up 116.8% YoY from $5.1M; gross margin 48.0% vs 21.2% in Q1 2025.
- Net loss $3.6M ($0.02/share) vs $5.7M ($0.03) in Q1 2025; cash $16.0M, no long-term debt.
- SSi Mantra installations 26 (+73% YoY); cumulative installed base 194 across 11 countries; 9,744 cumulative surgeries.
- Regulatory approvals: NMRA (Sri Lanka) and PPB (Kenya); telesurgery approvals in Indonesia and Philippines.
- March 2026 private placement raised ~$18.6M gross; FDA 510(k) review expected in 2026 and CE marking pathway.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1676163/000121390026055468/0001213900-26-055468-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1676163/000121390026055468/ea0290453-8k_ssinnovations.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-055468

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer